Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other Non-Current Assets (2016 - 2025)

Palisade Bio (PALI) has disclosed Other Non-Current Assets for 16 consecutive years, with $26000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $26000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $26000.0, a N/A change, with the full-year FY2024 number at $273000.0, up 950.0% from a year prior.
  • Other Non-Current Assets was $26000.0 for Q3 2025 at Palisade Bio, down from $171000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $643000.0 in Q1 2023 to a low of $12000.0 in Q4 2022.
  • A 5-year average of $153071.4 and a median of $26000.0 in 2021 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: soared 2373.08% in 2023, then plummeted 97.18% in 2025.
  • Palisade Bio's Other Non-Current Assets stood at $26000.0 in 2021, then crashed by 53.85% to $12000.0 in 2022, then soared by 116.67% to $26000.0 in 2023, then skyrocketed by 950.0% to $273000.0 in 2024, then plummeted by 90.48% to $26000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other Non-Current Assets are $26000.0 (Q3 2025), $171000.0 (Q2 2025), and $12000.0 (Q1 2025).